LANOXIN TAB 0.125MG DIN 00035319
Health Canada record
| Active ingredient(s) | DIGOXIN .125 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01AA05 DIGOXIN |
| Original market date | 31-Dec-1971 |
| Current status date | 02-Aug-2001 |
| Source | Health Canada DPD |
Establishment licence of the holder
Glaxo Wellcome S.A. — licence , not currently licensed, last inspection rating C (2025-05-09).
No Canadian shortage report is currently matched to this DIN.
Request a quote for LANOXIN TAB 0.125MG